CRMD

CorMedix Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$4.84

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %28.7 / %30

Non-compliant assets / Total market cap %1.7 / %30

Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.

Website

Analysis (Turkish): CRMD Hissesi Caiz mi, Helal mi? CorMedix Inc. Katılım Analizi